Hims & Hers Health HIMS 深 滬
等待開盤 12-23 09:30:00 美东时间
35.805
+0.245
+0.69%
華盛通- 最 高36.26
- 今 開35.91
- 成交量 444.75万股
- 最 低 35.30
- 昨 收 35.56
- 總市值 80.92亿
- 52周最高 72.98
- 市盈率 靜 67.28
- 換手率 0.00%
- 52周最低 23.97
- 委 比 -63.64%
- 總股本 2.26亿
- 歷史最高 72.98
- 量 比 1.42
- 振 幅 2.70%
- 歷史最低 2.72
- 每 手 1
- 風險率 11.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hims & Hers brings weight loss program to the U.K.
Hims & Hers (HIMS) is bringing access to its comprehensive weight loss program to the UK. After a detailed clinical assessment by GMC-registered doctors, eligible customers can now access transparent ...
12-10 18:11
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
HIMS Stock Forecast: Barclays Initiates With Buy Rating, Sees Over 20% Upside
Hims & Hers Health ($HIMS) stock recently earned a new Buy rating from Barc...
12-09 18:23
Hims & Hers to Acquire YourBio; No Financial Terms Disclosed
Acquisition Combines Hims & Hers' Leading Wellness Platform with YourBio's Patented, Virtually Painless Micro-Needle Technology to Redefine the Future of Blood SamplingHims & Hers Health, Inc. (NYSE:HIMS), the
12-03 22:04
The Short List — Top 10 Most Shorted Stocks Right Now
Here's a look at the top ten most shorted stocks in the market right now, including Wendy's, Lucid and Wolfspeed.
11-27 00:34
Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound
Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more aggressive push to regain U.S. market share. “Wegovy (semaglutide) injection 0.25 m...
11-17 21:25
Hims & Hers Stock (HIMS) Plunges despite New ‘Affordable’ Healthcare Platform
Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite...
11-14 02:49
Options Corner: Hims & Hers Health's Downturn Presents A Compelling Opportunity For Quants
Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for HIMS stock.
11-12 04:55
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
